Skip to main content
Science|Business

Bringing together industry, research and policy

Menu
  • The Network
  • News
  • Focus Areas
    • Technology Strategy Board
      • Become a member
      • Technology Strategy Board News
    • Future Proofing Medicines
    • Data Rules
      • Data Rules News
    • Framework Programmes
    • Climate news
    • EU Projects
      • TRESCA
      • ERC=Science²
  • Events
  • Reports
  • Communications Services
  • Advertising
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers
Advertising

Advertising

Study on common cause of blindness gets regulatory nod

Age-related macular degeneration (AMD) is a leading cause of blindness. The EMA has issued a Letter of Support to Innovative Medicines Initiative project MACUSTAR for its work on new measures to assess AMD in clinical trials.

10 May 2022
More news about
IHI
Advertising

Study of 8 million people supports neurological safety of COVID-19 vaccines

IMI-funded researchers found that COVID-19 vaccines do not raise the risk of developing four rare neurological disorders, but an increased risk was seen in unvaccinated infected people with the disease.

26 Apr 2022
More news about
IHI
Advertising

What impact do drugs have on the environment? The ePiE model offers a cheaper way to find out

Scientists from Innovative Medicines Initiative projects iPiE and PREMIER used a tool called ePiE to predict levels of ibuprofen in four major European river basins.

05 Apr 2022
More news about
IHI
Advertising

The opportunities and challenges of cancer-on-chip models in immunotherapy

Innovative Medicines Initiative project imSAVAR reviewed the state of ‘cancer-on-chip’ technology. While promising, problems with manufacturing to scale make them impractical for the moment.

22 Mar 2022
More news about
IHI
Advertising

New method matches drugs with faulty DNA replication, helping identify childhood cancer drug candidates

The Innovative Medicines Initiative project ITCC-P4 helped identify some of the best targets in childhood tumours that could be candidates for treatment with adult therapies.

08 Mar 2022
More news about
IHI
Advertising

Notorious superbug found to be a hidden disease outside hospital settings

Innovative Medicines Initiative project COMBACTE-CDI shed new light on the highly contagious bug Clostridioides difficile and sequenced the genomes of hundreds of strains for future researchers.

22 Feb 2022
More news about
IHI
Advertising

Two compounds progress to phase 1 trials, offering hope for new cancer drugs

The Innovative Medicines Initiative’s European Lead Factory has helped identify two drug candidates for cancer treatment that have now progressed to clinical testing.

08 Feb 2022
More news about
IHI
Advertising

Innovative Health Initiative seeks scientific and health experts to join advisory panel

IHI is looking for people who want to represent the scientific and healthcare communities in its Science and Innovation Panel. The panel will play a significant role in setting priorities and designing calls for proposals.

25 Jan 2022
More news about
IHI
Sponsored by Innovative Health Initiative

New resistance-busting antibiotic combination could extend use of ‘last-resort’ antibiotics

Researchers from the Innovative Medicines Initiative projects ENABLE and ELF have discovered a treatment that could reverse antibiotic resistance in some bacteria.

11 Jan 2022
More news about
IHI
Subscribe to IHI

The Network

The unique forum convening public and private sector leaders for networking, intelligence and debates on research and innovation.

More info

SB Network

Network Updates

These updates are republished press releases and communications from members of the Science|Business Network

New project coordinated by BSC aims to revolutionise breast cancer detection
19 May 2022   |   Barcelona Supercomputing Center
New Swiss alliance for capacity-building in PeaceTech
19 May 2022   |   École polytechnique fédérale de Lausanne (EPFL)
Aalto Startup Center celebrates its 25th anniversary as a pioneer in Finnish startup culture
19 May 2022   |   Aalto University
Finland, Japan open call for research cooperation
19 May 2022   |   CSC – IT CENTER FOR SCIENCE
EPFL: A new law unchains fusion energy
19 May 2022   |   École polytechnique fédérale de Lausanne (EPFL)

More Network Updates

Follow us on Twitter

Follow @scibus
Tweets by @scibus

Get the free Science|Business newsletter

Science|Business newsletter icon journalists track important R&D policy news across the globe - including the EU Horizon programme, COVID-19, AI and climate. 

Get the twice-weekly newsletter. 

  Register now!

The Horizon Papers: 2022 Edition

  • Digital, industry, space
  • Health
  • Civil security for society
  • MSCA
  • Climate, energy and mobility
  • Widening
  • Research infrastructures
  • European innovation ecosystems
  • Culture, creativity, inclusive society
  • Innovative Health Initiative, Calls 1 & 2 draft plans

Read all Horizon drafts

Jobs

Science|Business Executive Editor wanted
Science|Business seeks a CEE journalist
Science|Business is looking for an Industry journalist

Climate news

Horizon leaks

Read our expanding news coverage of climate technologies and policies here. 

Advertisement

Podcasts

Scien Business Podcast

Footer

  • The Network
  • News
  • Focus Areas
    • Framework Programmes
    • Health
    • Science Cloud
    • ERC=Science²
  • Events
  • Reports
  • Consultancy
  • Advertising
  • About Us
  • Contact

Home

Privacy   |   T&Cs   |   © 2022

  • The Network
  • News
  • Focus Areas
    • Technology Strategy Board
      • Become a member
      • Technology Strategy Board News
    • Future Proofing Medicines
    • Data Rules
      • Data Rules News
    • Framework Programmes
    • Climate news
    • EU Projects
      • TRESCA
      • ERC=Science²
  • Events
  • Reports
  • Communications Services
  • Advertising
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers